India Patent Office to Make Key Decision on Export of Roche, Pfizer Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - India's patent office will hold hearings Feb. 28 and 29 to decide whether India's Natco Pharmaceuticals should be awarded the country's first compulsory license to make and export to Nepal generic cancer drugs patented locally by Roche and Pfizer